News | Proton Therapy | October 29, 2018

Committee features experts in radiation and proton therapy from around the world to advance proton therapy care, ease adoption of new technologies

Victoria Advisory Committee for Proton Therapy Launched at ASTRO 2018

October 29, 2018 — At the 2018 American Society for Radiation Oncology (ASTRO) annual meeting, IBA announced the launch of the Victoria Advisory Committee, a consortium of worldwide radiation therapy experts to help define the future of proton therapy care.

The clinical community and IBA are joining forces to push the boundaries of proton therapy even further and treat all patients that could benefit from it. The Victoria Advisory Committee consists of clinical experts from the world’s leading cancer centers specializing in radiation and proton therapy and includes:

  • Jürgen Debus, M.D., Ph.D., Heidelberg University Hospital;
  • Tom Depuydt, Ph.D., ParTICle/UZ Leuven;
  • Adam Dicker, M.D., Ph.D., Jefferson University Hospitals;
  • Peyman Kabolizadeh, M.D., Ph.D., Beaumont Health Proton Therapy Center;
  • Zuofeng Li, D.Sc., University of Florida Health Proton Therapy Institute;
  • Carlos Vargas, M.D., Mayo Clinic Arizona, and other experts from prestigious institutions such as the University of Pennsylvania.

The clinical experts will help define future roadmaps as well as help to make clinical adoption easy for technologies such as:

  • Editable workflow — establishing a workflow framework to increase the treatment efficiency while navigating the growing treatment complexity;
  • Arc Therapy- — introducing rotational arc proton therapy as an additional treatment option; and
  • Adaptive technology — making online adaptive therapy a reality for proton therapy.
     

The first meeting of the Victoria Advisory Committee took place around the time of ASTRO 2018.

Kabolizadeh, medical director, Beaumont Health Proton Therapy Center, said, “We have recently announced the first irradiation of a Spot Scanning Proton Arc Therapy plan in our facility in Royal Oak, Mich., and we were excited to share the very promising initial results with the leading experts in the field during that meeting.”

Li, physics director, University of Florida Health Proton Therapy Institute (UFHPTI), stated: “As one of the pioneers in proton therapy with over 7,700 patients treated, we are delighted to contribute with our longstanding experience to advance proton therapy to the next level focusing on better treatment quality, reliability and efficiency.”

For more information: www.iba-worldwide.com

Related Content

News | Nuclear Imaging

December 3, 2021 — Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring ...

Time December 03, 2021
arrow
News | Coronavirus (COVID-19)

December 2, 2021 — Almost two-thirds of U.S. states failed to prioritize cancer patients for COVID-19 vaccinations ...

Time December 02, 2021
arrow
Videos | Radiation Therapy

Jeffrey T. Chapman, a medical student at the University of Texas Southwestern Medical Center, Explains how watching ...

Time November 24, 2021
arrow
Videos | Radiopharmaceuticals and Tracers

Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins ...

Time November 17, 2021
arrow
Videos | Radiation Therapy

The Elekta Harmony radiotherapy system gained FDA clearance in the summer of 2021 and was on display for the first time ...

Time November 17, 2021
arrow
News | Radiation Therapy

November 17, 2021 — Radiation can be a powerful cancer therapy, but it doesn’t work for everyone. A new study identifies ...

Time November 17, 2021
arrow
Videos | Radiation Oncology

This is a model of the Toshiba ion beam radiation therapy system at the American Society of Radiation Oncology (ASTRO) ...

Time November 16, 2021
arrow
News | Prostate Cancer

November 16, 2021 — A new Harvey L. Neiman Health Policy Institute study of nearly 800,000 men found that between 2011 ...

Time November 16, 2021
arrow
Videos | Radiation Oncology

Walter Curran, Jr. M.D., FACR, FASCO, GenesisCare global chief medical officer, discusses three technologies that are ...

Time November 16, 2021
arrow
Videos | Radiation Oncology

This is an example of a multileaf collimator (MLC) on the Accuray Thomotherapy radiation therapy system at the American ...

Time November 16, 2021
arrow
Subscribe Now